Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ$1.51+0.05 (3.42%)
Market Cap
$83.64M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
331 of 924
Rank in Industry
192 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
RANI Insider Trading Activity
RANI Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $49,967 | 2 | 67 |
Sells | $10,141,674 | 1 | 33 |
Related Transactions
| McKinley Kate | Chief Business Officer | 1 | $29,993 | 0 | $0 | $29,993 |
| Imran Talat | Chief Executive Officer | 1 | $19,974 | 0 | $0 | $19,974 |
| South Cone Investments Limited Partnership | 10 percent owner | 0 | $0 | 1 | $10.14M | $-10.14M |
About Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical …
Insider Activity of Rani Therapeutics Holdings, Inc.
Over the last 12 months, insiders at Rani Therapeutics Holdings, Inc. have bought $49,967 and sold $10.14M worth of Rani Therapeutics Holdings, Inc. stock.
On average, over the past 5 years, insiders at Rani Therapeutics Holdings, Inc. have bought $38.91M and sold $7.19M worth of stock each year.
Highest buying activity among insiders over the last 12 months: McKinley Kate (Chief Business Officer) — $29,993. Imran Talat (Chief Executive Officer) — $19,974.
The last purchase of 17,960 shares for transaction amount of $29,993 was made by McKinley Kate (Chief Business Officer) on 2024‑12‑13.
List of Insider Buy and Sell Transactions, Rani Therapeutics Holdings, Inc.
| 2024-12-13 | McKinley Kate | Chief Business Officer | 17,960 0.0313% | $1.67 | $29,993 | -12.05% | ||
| 2024-12-09 | Imran Talat | Chief Executive Officer | 10,296 0.018% | $1.94 | $19,974 | -24.35% | ||
| 2024-10-15 | Sale | South Cone Investments Limited Partnership | 10 percent owner | 3.83M 8.9999% | $2.65 | $10.14M | -25.00% | |
| 2023-12-06 | Imran Talat | Chief Executive Officer | 10,000 0.0173% | $2.27 | $22,700 | +30.75% | ||
| 2023-12-04 | Imran Talat | Chief Executive Officer | 5,000 0.0101% | $2.57 | $12,850 | +30.24% | ||
| 2023-11-29 | Imran Talat | Chief Executive Officer | 20,000 0.0409% | $2.05 | $41,000 | +68.97% | ||
| 2023-11-24 | Sale | Quiroga Cortes Isidoro Alfonso | 10 percent owner | 5.27M 10.2552% | $2.01 | $10.58M | +64.18% | |
| 2023-11-24 | South Cone Investments Limited Partnership | 10 percent owner | 5.27M 10.2552% | $2.01 | $10.58M | +64.18% | ||
| 2023-11-17 | BUTEL JEAN LUC | director | 50,500 0.0962% | $2.03 | $102,495 | +64.43% | ||
| 2023-11-16 | Nanavaty Maulik | director | 500 0.0009% | $1.98 | $990 | +66.67% | ||
| 2023-11-07 | Imran Talat | Chief Executive Officer | 5,000 0.0095% | $2.00 | $9,975 | +66.41% | ||
| 2023-05-12 | South Cone Investments Limited Partnership | 10 percent owner | 2,645 0.0104% | $3.98 | $10,529 | -10.57% | ||
| 2023-05-11 | South Cone Investments Limited Partnership | 10 percent owner | 2,610 0.0102% | $3.87 | $10,096 | -8.16% | ||
| 2023-05-08 | South Cone Investments Limited Partnership | 10 percent owner | 4,420 0.0183% | $4.46 | $19,733 | -15.19% | ||
| 2023-05-03 | South Cone Investments Limited Partnership | 10 percent owner | 2,040 0.0082% | $4.81 | $9,816 | -23.26% | ||
| 2023-04-28 | South Cone Investments Limited Partnership | 10 percent owner | 2,173 0.0086% | $4.71 | $10,225 | -23.51% | ||
| 2023-04-25 | South Cone Investments Limited Partnership | 10 percent owner | 4,423 0.0172% | $4.51 | $19,952 | -20.91% | ||
| 2023-04-24 | South Cone Investments Limited Partnership | 10 percent owner | 4,280 0.0169% | $4.67 | $19,994 | -22.77% | ||
| 2023-04-21 | South Cone Investments Limited Partnership | 10 percent owner | 4,100 0.0166% | $4.93 | $20,224 | -25.57% | ||
| 2023-04-20 | South Cone Investments Limited Partnership | 10 percent owner | 1,850 0.0074% | $5.32 | $9,851 | -31.82% |
Total: 83
*Gray background shows transactions not older than one year
Insider Historical Profitability
<0.0001%
| South Cone Investments Limited Partnership | 10 percent owner | 8302194 14.4919% | $12.12M | 64 | 1 | <0.0001% |
| Imran Talat | Chief Executive Officer | 494751 0.8636% | $722,336.46 | 5 | 0 | +49.09% |
| McKinley Kate | Chief Business Officer | 17960 0.0313% | $26,221.60 | 1 | 0 | |
| Quiroga Moreno Isidoro | 10 percent owner | 11731654 20.4781% | $17.13M | 2 | 0 | +50.37% |
| BUTEL JEAN LUC | director | 50500 0.0882% | $73,730.00 | 1 | 0 | +64.43% |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$4,786,289 | 136 | 5.55% | $90.47M | |
$49,091,668 | 110 | 13.11% | $78.19M | |
Rani Therapeutics Holdings, Inc. (RANI) | $155,580,641 | 77 | -24.21% | $83.64M |
$47,282,828 | 47 | -17.38% | $90.39M | |
$329,102,560 | 42 | 30.96% | $77.11M |
RANI Institutional Investors: Active Positions
| Increased Positions | 20 | +58.82% | 851,516 | +16.19% |
| Decreased Positions | 10 | -29.41% | 3M | -55.98% |
| New Positions | 15 | New | 714,265 | New |
| Sold Out Positions | 5 | Sold Out | 3M | Sold Out |
| Total Postitions | 44 | +29.41% | 3M | -39.79% |
RANI Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $1,086.00 | 2.15% | 709,828 | 0 | 0% | 2024-12-31 |
| Nan Fung Group Holdings Ltd | $755.00 | 1.5% | 493,584 | 0 | 0% | 2024-12-31 |
| United Services Automobile Association | $463.00 | 0.92% | 302,743 | 0 | 0% | 2024-12-31 |
| Two Sigma Investments, Lp | $446.00 | 0.88% | 291,381 | +291,381 | New | 2024-12-31 |
| Geode Capital Management, Llc | $263.00 | 0.52% | 171,573 | -688 | -0.4% | 2024-12-31 |
| Kestra Private Wealth Services, Llc | $183.00 | 0.36% | 119,620 | +119,620 | New | 2024-12-31 |
| Citadel Advisors Llc | $182.00 | 0.36% | 118,966 | +92,062 | +342.19% | 2024-12-31 |
| Two Sigma Advisers, Lp | $169.00 | 0.33% | 110,163 | +110,163 | New | 2024-12-31 |
| Northern Trust Corp | $162.00 | 0.32% | 105,634 | 0 | 0% | 2024-12-31 |
| Bank Of America Corp /De/ | $113.00 | 0.23% | 74,128 | -2,017 | -2.65% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.